Medical Condition News

RSS

Pancreatic cancer death rates in whites and blacks go in opposite directions

Pancreatic cancer death rates in whites and blacks have gone in opposite directions over the past several decades in the United States, with the direction reversing in each ethnicity during those years.

13 Nov 2013

African Americans with APOL1 gene variant experience faster progression of CKD

A large study co-authored by Penn Medicine published this week in the New England Journal of Medicine found that African Americans with the APOL1 gene variant experience faster progression of chronic kidney disease and have a significantly increased risk of kidney failure, regardless of their diabetes status.

13 Nov 2013

Aerobic exercise helps healthy aging adults improve memory, brain health and physical fitness

A new study conducted by researchers at the Center for BrainHealth at The University of Texas at Dallas published online in the open-access journal Frontiers in Aging Neuroscience found that engaging in a physical exercise regimen helps healthy aging adults improve their memory, brain health and physical fitness.

13 Nov 2013

Parental supervision at ages 11-14 lowers risk for problem gambling by age 22

Keeping an eye on your child can lower their odds for gambling by young adulthood, according to research conducted at Columbia University's Mailman School of Public Health. Adolescents who had poor parental supervision at age 11, and which continued to decline through age 14, were significantly more likely than their peers to be problem gamblers between ages 16-22.

12 Nov 2013

Researchers receive $7.5 million NIH grant to develop novel therapies for Alzheimer's disease

Researchers at Mayo Clinic in Florida, the University of Florida in Gainesville, and the Institute for Systems Biology in Seattle have received a $7.5 million grant from the National Institutes of Health to take a new and more expanded approach to identifying drug targets to treat and possibly prevent Alzheimer's disease.

12 Nov 2013

Studies suggest novel therapies for nicotine, heroin and gambling addiction

Studies released today suggest promising new treatments for nicotine and heroin addiction, and further our understanding of pathological gambling and heroin abuse in those suffering chronic pain.

12 Nov 2013

Furamidine drug may also be useful in treating cancers, immune-related diseases

A class of drugs used to treat parasitic infections such as malaria may also be useful in treating cancers and immune-related diseases, a new WSU-led study has found.

12 Nov 2013

Agilent collaborates with Baylor College of Medicine to provide CGH microarrays to researchers

Agilent Technologies Inc. has announced it is collaborating with Baylor College of Medicine's Medical Genetics Laboratories to provide customized CGH (comparative genomics hybridization) microarrays to researchers worldwide. Six new microarray designs unite the power of Baylor's data-rich expertise in genetics research with Agilent's microarray manufacturing capabilities to enable advanced discoveries in cancer and cytogenetics research.

12 Nov 2013

University of Sydney lecture to focus on the minds of teenage girls

Imagine a classroom of normal healthy teenage girls. As many as half of them may grow up and develop anxiety and depression. But which ones will they be?

12 Nov 2013

Hebrew University to participate in new European research project on chronic pain

The Hebrew University of Jerusalem is one of 11 universities, medical centers and research institutes in seven countries participating in ncRNAPain, a new European research project that aims at further exploring the biological mechanisms underlying chronic pain.

12 Nov 2013

Revalesio to conduct RNS60 Phase IIa clinical trial in RRMS patients

Revalesio Corporation is pleased to announce a new collaboration with noted neurologist Dr. Roland Martin, Head of Neuroimmunology and MS Research at the Department of Neurology, University Hospital Zurich. Dr. Martin will be conducting a Phase IIa clinical trial of RNS60 in patients with relapsing-remitting multiple sclerosis.

12 Nov 2013

FDA Advisory Committee votes in favor of Cochlear Nucleus Hybrid L24 Implant System

Cochlear Limited, the global leader in implantable hearing solutions, announced today that an advisory committee to the US Food and Drug Administration voted favorably on the Cochlear Nucleus Hybrid L24 Implant System.

12 Nov 2013

Nontoxic therapy shows encouraging results in blood samples from lupus patients

Northwestern Medicine- scientists have successfully tested a nontoxic therapy that suppresses Lupus in blood samples of people with the autoimmune disease.

12 Nov 2013

Researchers look to animal models to better understand human brain function, vision loss

Research released today reveals a new model for a genetic eye disease, and shows how animal models - from fruit flies to armadillos and monkeys - can yield valuable information about the human brain. The findings were presented at Neuroscience 2013, the annual meeting of the Society for Neuroscience and the world's largest source of emerging news about brain science and health.

12 Nov 2013

Shield Therapeutics files IND application with FDA to initiate ST10 Phase 3 study

Shield Therapeutics, an independent specialty pharmaceutical company focused on the development of mineral-derived hospital pharmaceuticals, today announces that it has filed an investigational new drug application with the US Food and Drug Administration to initiate a Phase 3 pivotal study of ST10, its novel oral iron-replacement therapy, for the treatment of iron deficiency anaemia in pre-dialysis patients with chronic kidney disease.

12 Nov 2013

Peripheral prism glasses provide simple mobility rehabilitation intervention for hemianopia

More than a million Americans suffer from hemianopia, or blindness in one half of the visual field in both eyes as the result of strokes, tumors or trauma. People with hemianopia frequently bump into walls, trip over objects, or walk into people on the side where the visual field is missing.

12 Nov 2013

New study stresses importance of studying freezing episodes in Parkinson's patients

A recent study, led by Ryan P. Duncan of Washington University at St. Louis, suggested patients with Parkinson's disease who suffer from freezing episodes are more likely to have impaired balance than those who do not. This is an important discovery as Parkinson's disease typically develops in elderly patients, who cannot afford to be unstable, lose balance and potentially fall, which could result in major injuries.

12 Nov 2013

Helsinn grants exclusive commercialization rights to Chugai Pharma Marketing for anamorelin drug

Swiss-based Helsinn group has granted Chugai Pharma Marketing Ltd., a wholly-owned subsidiary of Chugai Pharmaceutical Co., Ltd., exclusive commercialization rights to their innovative ghrelin receptor agonist, anamorelin, for the three major European pharma markets.

12 Nov 2013

Researchers discover new pathway for treating allergic diseases

A collaboration among researchers in Israel and the United States has resulted in the discovery of a new pathway that has broad implications for treating allergic diseases - particularly eosinophil-associated disorders.

12 Nov 2013

Researchers develop model that predicts earlier prediction of Alzheimer's disease in older adults

Using scores obtained from cognitive tests, Johns Hopkins researchers think they have developed a model that could help determine whether memory loss in older adults is benign or a stop on the way to Alzheimer's disease.

12 Nov 2013

Medical Condition News

Pancreatic cancer death rates in whites and blacks go in opposite directions

African Americans with APOL1 gene variant experience faster progression of CKD

Aerobic exercise helps healthy aging adults improve memory, brain health and physical fitness

Parental supervision at ages 11-14 lowers risk for problem gambling by age 22

Researchers receive $7.5 million NIH grant to develop novel therapies for Alzheimer's disease

Studies suggest novel therapies for nicotine, heroin and gambling addiction

Furamidine drug may also be useful in treating cancers, immune-related diseases

Agilent collaborates with Baylor College of Medicine to provide CGH microarrays to researchers

University of Sydney lecture to focus on the minds of teenage girls

Hebrew University to participate in new European research project on chronic pain

Revalesio to conduct RNS60 Phase IIa clinical trial in RRMS patients

FDA Advisory Committee votes in favor of Cochlear Nucleus Hybrid L24 Implant System

Nontoxic therapy shows encouraging results in blood samples from lupus patients

Researchers look to animal models to better understand human brain function, vision loss

Shield Therapeutics files IND application with FDA to initiate ST10 Phase 3 study

Peripheral prism glasses provide simple mobility rehabilitation intervention for hemianopia

New study stresses importance of studying freezing episodes in Parkinson's patients

Helsinn grants exclusive commercialization rights to Chugai Pharma Marketing for anamorelin drug

Researchers discover new pathway for treating allergic diseases

Researchers develop model that predicts earlier prediction of Alzheimer's disease in older adults

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Latest News